Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis - PubMed (original) (raw)
Case Reports
. 2011 Nov;66(11):2677-8.
doi: 10.1093/jac/dkr337. Epub 2011 Aug 16.
- PMID: 21846669
- DOI: 10.1093/jac/dkr337
Case Reports
Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis
Neil R H Stone et al. J Antimicrob Chemother. 2011 Nov.
No abstract available
Similar articles
- Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
Docobo-Pérez F, Nordmann P, Domínguez-Herrera J, López-Rojas R, Smani Y, Poirel L, Pachón J. Docobo-Pérez F, et al. Int J Antimicrob Agents. 2012 Mar;39(3):251-4. doi: 10.1016/j.ijantimicag.2011.10.012. Epub 2011 Dec 7. Int J Antimicrob Agents. 2012. PMID: 22154856 - Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.
Cobo J, Morosini MI, Pintado V, Tato M, Samaranch N, Baquero F, Cantón R. Cobo J, et al. Diagn Microbiol Infect Dis. 2008 Mar;60(3):319-22. doi: 10.1016/j.diagmicrobio.2007.09.017. Epub 2007 Nov 9. Diagn Microbiol Infect Dis. 2008. PMID: 17996417 - In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Spanu T, De Angelis G, Cipriani M, Pedruzzi B, D'Inzeo T, Cataldo MA, Sganga G, Tacconelli E. Spanu T, et al. Antimicrob Agents Chemother. 2012 Aug;56(8):4516-8. doi: 10.1128/AAC.00234-12. Epub 2012 May 29. Antimicrob Agents Chemother. 2012. PMID: 22644031 Free PMC article. - [Nosocomial infection due to ESBL-producing bacteria].
Yagi T. Yagi T. Nihon Rinsho. 2003 Mar;61 Suppl 3:90-4. Nihon Rinsho. 2003. PMID: 12717952 Review. Japanese. No abstract available. - [NDM-1: the superbug?].
Pittalis S, Ferarro F, Puro V. Pittalis S, et al. Infez Med. 2011 Dec;19(4):224-34. Infez Med. 2011. PMID: 22212161 Review. Italian.
Cited by
- Discovery of novel new Delhi metallo-β-lactamases-1 inhibitors by multistep virtual screening.
Wang X, Lu M, Shi Y, Ou Y, Cheng X. Wang X, et al. PLoS One. 2015 Mar 3;10(3):e0118290. doi: 10.1371/journal.pone.0118290. eCollection 2015. PLoS One. 2015. PMID: 25734558 Free PMC article. - Clinical management of infections caused by multidrug-resistant Enterobacteriaceae.
Delgado-Valverde M, Sojo-Dorado J, Pascual A, Rodríguez-Baño J. Delgado-Valverde M, et al. Ther Adv Infect Dis. 2013 Apr;1(2):49-69. doi: 10.1177/2049936113476284. Ther Adv Infect Dis. 2013. PMID: 25165544 Free PMC article. Review. - NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.
Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. Wu W, et al. Clin Microbiol Rev. 2019 Jan 30;32(2):e00115-18. doi: 10.1128/CMR.00115-18. Print 2019 Mar 20. Clin Microbiol Rev. 2019. PMID: 30700432 Free PMC article. Review. - Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
Chibabhai V, Nana T, Bosman N, Thomas T, Lowman W. Chibabhai V, et al. Infection. 2018 Feb;46(1):1-13. doi: 10.1007/s15010-017-1070-8. Epub 2017 Sep 15. Infection. 2018. PMID: 28916900 Review. - Breakthrough and persistent bacteremia due to serotype K1 Klebsiella pneumoniae in an immunocompetent patient.
Maruki T, Taniyama D, Tsuchiya Y, Adachi T. Maruki T, et al. IDCases. 2020 Jun 27;21:e00893. doi: 10.1016/j.idcr.2020.e00893. eCollection 2020. IDCases. 2020. PMID: 32642439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical